Iain Dukes - 07 Jun 2024 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Iain D. Dukes
Issuer symbol
IKNA
Transactions as of
07 Jun 2024
Net transactions value
$0
Form type
4
Filing time
10 Jun 2024, 16:15:06 UTC
Previous filing
03 Apr 2024
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +17,520 $0.000000 17,520 07 Jun 2024 Common Stock 17,520 $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.